retatrutide phase 2 isn't a GLP-1. It's not a dual agonist. It's a triple hormone receptor agonist — activating GIP, GLP-1, and glucagon simultaneously. Three receptors. Three mechanisms. One protocol. Swipe to see what The New Gold Standard: Retatrutide

The large increase in prescriptions for these three GLP-1 drugs for overweight and obesity aligns with increasing public interest from 2017 to 2024 as demonstrated by other research

The overall result was that 10/16 of the low LH subjects had at least one period during the 16-week treatment phase, and 3/8 of the normal LH subjects

According to the authors, the funders had no role in the study's design, data collection, analysis, interpretation, manuscript preparation, review, approval, or publication decisions

The role of alpha lipoic acid in female and male infertility: A systematic review

Koeppen BM, Stanton BA (2013) Renal physiology, 5th edn

We understand that patients across the region are seeking advanced, personalized medical solutions for weight management and metabolic health